Description

High Court of Judicature at Bombay Official Liquidator Report regarding Biowin Pharma (India) Ltd. and multiple other companies in liquidation proceedings.

Summary

This document is an Official Liquidator Report No. 160 of 2025 filed in the High Court of Judicature at Bombay concerning Biowin Pharma (India) Ltd. (in Liquidation) in Company Petition No. 775 of 2001. The document was uploaded on January 19, 2026 and includes multiple consolidated Official Liquidator Reports (OLR Nos. 160, 3, 4, 5, 7, 11, 14, 15, 17, 18, 19, 20, 21, and 26 of 2025-2026) covering various companies in liquidation proceedings under the Companies Act, 1956.

Key Points

  • Official Liquidator Report No. 160 of 2025 pertains to Biowin Pharma (India) Ltd. (in Liquidation), filed under Company Petition No. 775 of 2001
  • Petitioner: Manipal Finance Corporation Ltd.
  • Document uploaded on January 19, 2026 and downloaded on January 20, 2026
  • Multiple other company liquidation proceedings consolidated in this order including Sujay Enterprise (India) Pvt. Ltd., Archdeep Interior Infra Pvt. Ltd., Shree Ramkrishna Electro Controls Limited, Filtrona India Ltd., and others
  • Proceedings conducted under Companies Act, 1 of 1956
  • Document digitally signed by Meera Mahesh Jadhav (Court official)

Regulatory Changes

No new regulatory changes are introduced in this document. This is a procedural court order relating to ongoing liquidation proceedings under the existing Companies Act, 1956 framework.

Compliance Requirements

  • Official Liquidators must continue to manage the liquidation proceedings for the companies listed
  • Creditors and stakeholders must comply with court directions regarding the liquidation process
  • All parties involved in the company petitions must adhere to the court’s orders and timelines

Important Dates

  • January 19, 2026: Document uploaded to court system
  • January 20, 2026: Document downloaded at 08:01:06
  • Original Filing Dates: Various company petitions filed between 1992 and 2016
    • CP No. 775 of 2001 (Biowin Pharma)
    • CP No. 127 of 2012 (Sujay Enterprise)
    • CP No. 879 of 2015 (Archdeep Interior Infra)
    • CP No. 464 of 2011 (Shree Ramkrishna Electro Controls)
    • And multiple others

Impact Assessment

Market Impact: Low - The companies mentioned are already in liquidation proceedings, some dating back to the 1990s and early 2000s. The order represents routine court proceedings rather than new market events.

Operational Impact: Limited to creditors, shareholders, and other stakeholders of the companies in liquidation. The Official Liquidator continues to manage asset realization and distribution processes.

Investor Impact: Minimal for general market investors. Relevant only to specific creditors and shareholders of the companies under liquidation who may be awaiting asset distribution or settlement of claims.

Legal Significance: Documents the ongoing judicial oversight of liquidation proceedings under the Companies Act, 1956, demonstrating the extended timeframes often required for complex insolvency resolution.

Impact Justification

Relates to liquidation proceedings of multiple companies under Companies Act 1956. Limited market impact as companies are already in liquidation. Primarily relevant for creditors and stakeholders of listed entities.